Purpose of review Spondyloarthritis (SpA) is a chronic immune-mediated inflammatory disease of unknown origin. Here we aim to review whether SpA is driven by T-cell and/or B-cell autoreactivity or by abnormal innate immune responses.
Autoimmune diseases are characterized by unchecked T-cell and/or B-cell reactivity to self-antigens, leading to chronic tissue inflammation. Although the causative autoantigens often remain partially elusive, prototypical autoimmune diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) share a number of common features. Firstly, they display common genetic risk factors such as single-nucleotide polymorphisms (SNPs) in molecules related to T cell receptor/B cell receptor signaling and central tolerance, with, as prime example, PTPN22 [1] . Secondly, they are characterized by a marked female predominance. Thirdly, they are associated with disease-specific autoantibodies such as anticitrullinated protein antibodies in RA and anti-dsDNA antibodies in SLE. Finally, they respond well to T-cell or B-cell-targeted treatments, such as abatacept and rituximab in RA.
An important number of immune-mediated inflammatory diseases (IMIDs) do not share these common autoimmune features, suggesting that chronic inflammation in these disorders is not primarily driven by autoreactive T or B lymphocytes. In an important conceptual study, McGonagle and McDermott [2] proposed to classify IMIDs in a continuum ranging from autoimmunity to autoinflammation, the latter being driven by innate immune responses to specific tissue triggers, such as microorganisms or microtrauma ( Table 1 ). The best known examples of autoinflammation are the rare fever syndromes: tumor necrosis factor receptorassociated periodic syndrome (TRAPS) and familial Mediterranean fever (FMF). These diseases are caused by single gene defects affecting inflammatory cytokine pathways and leading to aberrant production of IL-1b or tumor necrosis factor (TNF) [3] . Apart from the prototypical monogenic autoinflammatory conditions, polygenic autoinflammatory diseases are viewed as the result of a combination between genetic risk factors and exogenous stress. Accordingly, these diseases respond better to cytokine blockade than to therapies targeting the acquired immune system. Spondyloarthritis (SpA) is a polygenic IMID characterized by inflammation of the spine and peripheral joints, as well as extra-articular manifestations, such as inflammatory bowel disease (IBD), uveitis and psoriasis [4 & ]. SpA is not associated with typical autoimmune genes, but displays polymorphisms in genes involved in innate immune recognition (CARD9) and cytokine signaling pathways, such as the TNF [TNF receptor superfamily member 1A, TNF receptor type 1-associated  death domain protein (TRADD), TNF receptor superfamily member 15 (TNFSF15)], IL-1 (IL1A, IL1R2),  and IL-23/IL-17 [IL-23R , signal transducer and activator of transcription 3 (STAT3)] axis [5 & ,6-8]. Moreover, SpA does not show a female predominance and is not associated with disease-specific autoantibodies. Finally, T-cell or B-cell-targeted therapies such as abatacept, alefacept, efalizumab and rituximab showed very modest therapeutic efficacy in SpA [9] [10] [11] [12] [13] [14] [15] [16] [17] ( Table 2 ). The lack of classical autoimmune features leads to the hypothesis that adaptive immune responses are not of primary importance in SpA. Furthermore, the genetic background and the importance of bacterial [18] and mechanical [19] stress point towards an autoinflammatory origin of the disease.
HLA-B27: DRIVER OF AUTOIMMUNITY OR AUTOINFLAMMATION?
Although SpA displays many autoinflammatory features, it has originally been classified as a 'mixed' disease, due to the strong genetic association with human leukocyte antigen B27 (HLA-B27), which suggested a pathogenic involvement of autoreactive CD8þ T cells. HLA-B27 accounts for c. 40% of the genetic risk and its direct etiopathogenetic role has been demonstrated by the development of experimental SpA in HLA-B27/hb2m transgenic rats [20] . As major histocompatibility complex class I molecule, the main function of HLA-B27 is to present antigens to CD8þ T lymphocytes after forming a complex with beta-2 microglobulin (b2m). In this context, HLA-B27 was hypothesized to present HLA-B27-dependent UPR leads to augmented IL-23 production, but the role of UPR in vivo remains to be investigated in more detail.
KEY POINTS
Alternative macrophage polarization is a hallmark of SpA.
Innate immune cells rather than T cells are the main producers of IL-17 in SpA. specific bacterial peptides and thereby activate cytotoxic T cells, which could subsequently cross-react with self-peptides [21] . The 'arthritogenic peptide' concept, however, was severely challenged by two studies [22, 23] indicating that the absence of functional CD8þ T cells does not prevent disease in the HLA-B27/hb2m rat model. More recently, two alternative hypotheses were proposed to explain the role of HLA-B27 in SpA pathogenesis ( Fig. 1 ). Both hypotheses are independent of antigen presentation, but related to intrinsic biochemical properties of the cysteine residue in the beta-pocket of HLA-B27. The first hypothesis follows the observation that HLA-B27 has the tendency to form homodimers on the cell surface [24] . HLA-B27 dimers are recognized by specific killer cell immunoglobulin-like receptors (KIRs) and leukocyte immunoglobulin-like receptors (LILRs) on natural killer (NK) and T cells, leading to cell activation and production of pro-inflammatory mediators [25] . Unfortunately, this hypothesis is not able to explain why other HLA-B molecules or HLA-B27 subtypes, which also form homodimers, are not associated with SpA [26 & ,27]. The second hypothesis is based on the tendency of HLA-B27 to misfold inside the endoplasmic reticulum (ER) and generate a so-called unfolded protein response (UPR) [28 & ,29] . The UPR leads to the induction of ER chaperones and the activation of NF-kB, followed by increased production of pro-inflammatory cytokines. ER stress as a result of chemical agents or HLA-B27 up-regulation was especially shown to increase the Toll-like receptor (TLR)-induced IL-23 production by bone marrow-derived macrophages (BMDMs) from HLA-B27/Hub2m transgenic rats [30] . ER stress in human dendritic cells was also shown to preferentially increase the production of IL-23 after TLR stimulation [31 & ]. Circumstantial evidence that HLA-B27-induced UPR may be important in SpA is provided by the facts that IL-23 is highly expressed in the bowel of HLA-B27/hub 2 m transgenic rats [30] , as well as Crohn and SpA patients [32] , and that inhibition of the IL-23p40 unit showed a good clinical efficacy in SpA-related diseases, such as Crohn's disease, psoriasis, and psoriatic arthritis (PsA) [33] [34] [35] [36] . It has to be noted, however, that overexpresison of the b2m in the HLA-B27/hb2m rat model in order to reduce the UPR did not prevent, but rather modulated the disease phenotype [37] . Additionally, it was recently reported that the increased lipopolysaccharide (LPS)-induced IL-23 production by monocyte-derived macrophages of ankylosing spondylitis (AS) patients in comparison with healthy donors is not associated with the induction of an UPR, even after up-regulation of HLA-B [38 & ]. Thus, these two studies question the in-vivo relevance of HLA-B27-induced UPR in SpA.
Although the relative contribution of each of these pathways (antigen presentation, homodimer formation and endoplasmic misfolding) to the pathology remains to be fully determined, an autoinflammatory role for HLA-B27 is further supported by the importance of tissue stress as a trigger for SpA. Tissue stress is indicated by the typical localization of the lesions at sites of high mechanical stress (entheses, spine, and the large joints of the lower limbs) and by the association between SpA and bacterial infections. The latter is clinically evidenced by the development of reactive arthritis after gastrointestinal or genito-urethral infections and by the absence of disease in HLA-B27/hb2m rats which were kept in germ-free conditions [39] . In addition, HLA-B27-expressing human monocytic cells were less able to clear Salmonella infection [40] and were more permissive for intracellular Salmonella replication, due to HLA-B27 misfolding [41] . Taken together, these findings support the hypothesis that HLA-B27 in conjunction with mechanical or bacterial stress leads to abnormal innate immune responses.
MACROPHAGE POLARIZATION
As HLA-B27 modifies the innate immune responses of myeloid cells in general and macrophages in particular, it is crucial to understand the phenotypical and functional heterogeneity of macrophages in chronic inflammation. During their maturation process, macrophages can be polarized by local mediators into distinct functional subsets. Initially, two main macrophage types were described based on their pro-inflammatory versus anti-inflammatory functions. Classically activated macrophages (M1) are specialized in the clearance of intracellular pathogens, whereas alternatively activated macrophages (M2) have immunoregulatory properties and are involved in scavenging debris, angiogenesis, and tissue repair. IFN-g is the prototypic inducer of M1, whereas numerous stimuli such as IL-4, IL-10, and co-stimulation with immune complexes (ICs) and TLR ligands, are described to induce different M2 subsets [42] . Studying the phenotype and function of macrophages in vivo has proven to be a major challenge, since macrophages are a highly heterogeneous and dynamic cell population. Three issues arise from the effort to validate reliable markers, in order to identify distinct macrophage subsets in vivo.
Firstly, extrapolation of data from animal models into humans should be done carefully, due to important interspecies differences. Secondly, it needs to be assessed whether in-vitro polarized macrophages are a good model for the in-vivo polarization. Finally, it is largely unknown whether a certain macrophage phenotype can be associated with a unique functional profile, or whether distinct phenotypic subsets display overlapping functions.
MACROPHAGE POLARIZATION IN SPONDYLOARTHRITIS
Immunohistologic analysis of the synovial tissue in chronic inflammatory arthritis showed a predominant infiltration with innate immune cells, and especially macrophages. Tissue macrophages are described to consist of resident macrophages and monocytes which are recruited in inflammatory conditions and differentiate upon tissue entry. The number of macrophages in the inflamed synovium was shown to correlate with the disease activity [43, 44] and to decrease after clinically efficient treatment in both RA [45] and SpA [46, 47] . Interestingly, despite similar numbers of synovial macrophages and overall levels of synovial inflammation, the expression of CD163, which is a known marker for M2 macrophages, was repeatedly found to be significantly increased in SpA compared with RA synovitis [44, [48] [49] [50] [51] [52] [53] . The expression of CD163 was also increased in the colonic mucosa of SpA [48] and Crohn's patients versus colitis ulcerosa patients and healthy controls [54] , illustrating the link between the two diseases. Furthermore, gene expression analysis of monocyte-derived myeloid cells revealed a 'reversed' IFN-g signature in human SpA [55] as well as in HLA-B27 transgenic rats [56] . Taken together, these data suggest a preferential M2 over M1 polarization in SpA, but formal proof of this hypothesis is still awaited.
MACROPHAGE FUNCTION IN SPONDYLOARTHRITIS
Although the functional consequences of this preferential M2 polarization remain speculative, a direct link to disease pathogenesis was suggested by the correlation of the number of CD163þ synovial macrophages with disease activity and HLA-B27 positivity in SpA [49] . In agreement with the reported anti-inflammatory function of soluble CD163 [57] , CD163 expression was also associated with impaired lymphocyte activation in SpA synovitis [49] . Such an immunomodulating effect of M2 macrophages may relate to disease pathogenesis, as suggested by the intracellular persistence of Chlamydia, which is also a causative agent for reactive arthritis, after alternative macrophage polarization in the presence of IL-4 [58] . Analysis of synovial fluid [59] further supported the idea of a shift in the M1/M2 balance as, despite comparable degrees of overall synovial inflammation and IL-6 levels, the M1 pro-inflammatory cytokines TNF, IL-1 and IL-12p40 were relatively decreased in SpA versus RA. TNF, IL-1 and, as previously discussed, IL-23 are the main macrophagederived pro-inflammatory cytokines of interest in the pathophysiology of SpA. The pathogenic role of TNF is evident as TNF blockade resulted in a significant decrease in disease activity [60 & ], accompanied by a rapid decrease in the number of synovial macrophages, polymorphonuclear neutrophils, and T cells [46, 47, 61] . Additional arguments for the role of TNF in SpA are the genetic susceptibility conferred by TNF-R1 and TRADD [6, 7] and the TNF-R1-dependent arthritis and colitis in TNF(Delta)ARE mice [62] . Despite this overwhelming evidence for a pathogenic role of TNF, it remains poorly understood which form of TNF (soluble or transmembrane), which receptor (TNFR1 or TNFR2) and which target cells are predominantly involved in human SpA. In Crohn's disease, which shows a broad clinical and pathogenic overlap with SpA, decreased TNF levels as a result of enhanced lysosomal degradation were suggested to be responsible for defective bacterial clearance [63] . Moreover, overexpression of soluble TNF in mice leads to a severe and destructive polysynovitis reminiscent of human RA [64] , whereas transmembrane TNF transgenic mice develop axial en peripheral joint involvement resembling human SpA [65] . Further investigation of TNF biology in human SpA remains thus warranted to define its exact pathophysiological role.
In contrast to TNF, only few data are available on IL-1 in SpA. A role for this second major macrophage-derived pro-inflammatory cytokine is again suggested by genetic polymorphisms in genes related to the IL-1 pathway [8] . However, biological investigation of IL-1 in SpA is lacking and proof-ofconcept trials with the soluble IL-1R antagonist anakinra failed to consistently show clinical efficacy [66] .
Apart from the major pro-inflammatory cytokines (TNF, IL-1, and IL-23), macrophages are also the major source of IL-10. This prototypical immunoregulatory cytokine was shown to play a key role in the maintenance of immunological tolerance and is mainly produced by M2 macrophages. Dysregulation of the IL-10 pathway was initially reported in Crohn's disease [67, 68] and genetic defects in the IL-10R lead to severe juvenile-onset colitis [69] . Whether the IL-10 pathways are also dysregulated in SpA remains to be investigated in more detail, but the reduced constitutive and bacterial-induced IL-10 production by splenocytes from HLA-B27/ hb2m rats [70] and reduced IL-10 production by AS PBMCs after stimulation with autologous commensal enteric bacteria [71] are compatible with this hypothesis.
THE ROLE OF OTHER INNATE IMMUNE CELLS IN SPONDYLOARTHRITIS
As discussed, functional and genetic data suggest an essential role for the IL-23/STAT3 pathway in SpA. Polymorphisms in the IL-23R and STAT3 genes are associated with disease predisposition in SpA, as well as IBD [72, 73] . Moreover, blockade of IL-17A, an effector cytokine triggered by IL-23/STAT3 signaling, showed good clinical efficacy in a proof-ofconcept clinical trial in AS [74 & ]. Whereas the IL-23/IL-17 axis has mainly been studied in canonical Th17 cells, the data on the number of Th17 cells in peripheral blood of SpA remain inconsistent [75, 76] . More importantly, direct analysis of the axial and peripheral joints of SpA patients showed that IL-17 was not expressed by T cells, but rather by innate immune cells, including mast cells and neutrophils [ ]. Accordingly, targeting mast cells with the c-kit inhibitor imatinib induced a marked decrease of IL-17 production by SpA synovial biopsies [53] . These data are consistent with the fact that IL-23 was shown to trigger IL-17 production not only by Th17 cells, but also by gd T cells [83 & ,85] , innate lymphoid cells (ILCs), which are the main producers of IL-17 in experimental colitis [84 & ,86 & ], mast cells and neutrophils, but potentially also NK cells, which can be directly stimulated by HLA-B27 homodimers. The exact role and contribution of these different cell types to the pathophysiology of SpA remain to be investigated in detail.
CONCLUSION
The genetic risk factors related to the innate cell biology and the predominance of innate versus adaptive immune responses in SpA indicate a prominent autoinflammatory component, according to McGonagle and McDermott's [2] classification. The importance of the intrinsic, rather than the antigenpresenting properties of HLA-B27 further suggests that SpA belongs to the same class of polygenic autoinflammatory disorders as Crohn's and Behcet's diseases. However, as innate and adaptive immune responses are intimately entangled and chronic tissue inflammation is often accompanied by secondary T-cell and B-cell activation, a dichotomous classification might prove too simplistic. The major challenge is to define the exact phenotype and function of innate immune cells, focusing on the target tissues, and to relate this biologically to the genetic and environmental factors involved in disease pathogenesis. Better understanding of the innate immune alterations in SpA may help to fine tune anticytokine therapies. It may also lead to new therapeutic strategies, such as direct targeting of Overview of the IL-23-responsive immune cells which are involved in the pathogenesis of human IBD and SpA. Th17 cells were shown to play a pathogenetic role in IBD, where they can exert both inflammatory and immunosuppressive effects [80, 81] , but there are indications that they are also involved in axial SpA [82] . IL-23Rþ gd T cells were found to be increased in peripheral blood of AS and PsA patients compared with RA patients and healthy individuals [83 & ]. IL-23 was further shown to control the function of innate lymphoid cells (ILCs), which were selectively increased in the inflamed intestine of Crohn's disease, but not ulcerative colitis patients [ 
